It’s this inflammation of the lining of your nose that produces the telltale stuffiness sensation of chronic nasal congestion ...

Full results from the trial will be presented at an upcoming medical meeting. Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps ...

Results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and congestion in CRSwNP.

Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...

Six months after Amgen and AstraZeneca reported promising results for Tezspire (t | A phase 3 study has shown that ...

AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...

(IN BRIEF) A Phase III trial of Tezspire (tezepelumab) by AstraZeneca and Amgen has shown significant benefits for patients ...

The Conifer Park warns that overuse of nasal sprays can cause long-term effects such as chronic congestion, inability to identify triggers, worsening congestion, and withdrawal symptoms such as, ...

The once and future president months ago said that he would kill the vehicle tolling program, but if Gov. Kathy Hochul acts ...

A deviated septum occurs when you have two different-sized nasal passageways which can cause one-sided congestion.